NRD
CLBT icon

Nebula Research & Development’s Cellebrite CLBT Stock Holding History

Nebula Research & Development’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-77,823
Closed -$1.25M – 173
2025
Q2 		$1.25M Sell
77,823
-5,610
-7% -$100K 0.11% 324
2025
Q1 		$1.62M Buy
83,433
+51,788
+164% +$1.09M 0.15% 220
2024
Q4 		$697K Buy
+31,645
New +$609K 0.08% 427
2024
Q3 		– Sell
-11,112
Closed -$133K – 960
2024
Q2 		$133K Buy
+11,112
New +$124K 0.02% 762

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Nebula Research & Development's CLBT Position: Q3 2025 in Review

Nebula Research & Development sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 77,823 shares — an estimated $1.25M sold.

Nebula Research & Development first reported a position in CLBT in Q2 2024 and held it in 4 quarters. The position peaked at $1.62M in Q1 2025. 196 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Nebula Research & Development reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 77,823 Cellebrite shares in Q3 2025, an estimated $1.25M.
  • Nebula Research & Development first reported a position in Cellebrite in Q2 2024 and held it in 4 quarters.
  • Nebula Research & Development's Cellebrite position peaked at $1.62M in Q1 2025.
  • 196 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.